MX344120B - Vacunas y composiciones contra streptococcus pneumoniae. - Google Patents

Vacunas y composiciones contra streptococcus pneumoniae.

Info

Publication number
MX344120B
MX344120B MX2013008358A MX2013008358A MX344120B MX 344120 B MX344120 B MX 344120B MX 2013008358 A MX2013008358 A MX 2013008358A MX 2013008358 A MX2013008358 A MX 2013008358A MX 344120 B MX344120 B MX 344120B
Authority
MX
Mexico
Prior art keywords
streptococcus pneumoniae
vaccines
compositions against
against streptococcus
prophylactically
Prior art date
Application number
MX2013008358A
Other languages
English (en)
Other versions
MX2013008358A (es
Inventor
Gierahn Todd
Malley Richard
Original Assignee
Genocea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genocea Biosciences Inc filed Critical Genocea Biosciences Inc
Publication of MX2013008358A publication Critical patent/MX2013008358A/es
Publication of MX344120B publication Critical patent/MX344120B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Abstract

La presente invención se refiere a Streptococcus pneumoniae supone un problema de salud importante, especialmente en pacientes muy jóvenes, ancianos o inmunodeficientes. La presente descripción proporciona, entre otras cosas, ciertas vacunas y composiciones farmacéuticas muy eficaces contra Streptococcus pneumoniae. Los antígenos se pueden utilizar de forma terapéutica o profiláctica.
MX2013008358A 2011-01-20 2012-01-20 Vacunas y composiciones contra streptococcus pneumoniae. MX344120B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161434818P 2011-01-20 2011-01-20
PCT/US2012/022128 WO2012100234A1 (en) 2011-01-20 2012-01-20 Vaccines and compositions against streptococcus pneumoniae

Publications (2)

Publication Number Publication Date
MX2013008358A MX2013008358A (es) 2013-09-02
MX344120B true MX344120B (es) 2016-12-06

Family

ID=46516136

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008358A MX344120B (es) 2011-01-20 2012-01-20 Vacunas y composiciones contra streptococcus pneumoniae.

Country Status (14)

Country Link
US (2) US9393294B2 (es)
EP (1) EP2665490B1 (es)
JP (1) JP6126993B2 (es)
KR (1) KR20140017554A (es)
CN (2) CN103501809B (es)
AU (2) AU2012207088A1 (es)
BR (1) BR112013018642A2 (es)
CA (1) CA2861313A1 (es)
IL (1) IL227554A (es)
MX (1) MX344120B (es)
MY (1) MY163871A (es)
RU (1) RU2623174C2 (es)
SG (2) SG192060A1 (es)
WO (2) WO2012100234A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107126557A (zh) * 2009-06-29 2017-09-05 健诺西生物科学公司 抗肺炎链球菌的疫苗和组合物
JP2013525271A (ja) 2010-03-12 2013-06-20 チルドレンズ メディカル センター コーポレーション 免疫原およびそのスクリーニング方法
WO2012100234A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
US9765125B2 (en) * 2012-01-20 2017-09-19 Genocea Biosciences, Inc. Fused antigen vaccines and compositions against Streptococcus pneumoniae
WO2014124228A1 (en) 2013-02-07 2014-08-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
US10126305B2 (en) * 2013-06-25 2018-11-13 University of Pittsburg—Of the Commonwealth System of Higher Education Proteomic biomarkers of sepsis in elderly patients
KR101587859B1 (ko) * 2013-09-11 2016-01-25 한국기초과학지원연구원 폐렴연쇄상구균의 NagA 단백질을 포함하는 폐렴연쇄상구균의 감염 진단용 조성물
CA2931570A1 (en) * 2013-12-03 2015-06-11 Virometix Ag Proline-rich peptides protective against s. pneumoniae
CN106822885B (zh) 2017-02-16 2020-06-30 清华大学 肺炎链球菌疫苗
GB201807380D0 (en) * 2018-05-04 2018-06-20 Karlsson Roger Biomarkers for detecting microbial infection
CN112969474A (zh) 2018-09-12 2021-06-15 艾芬尼维克斯公司 多价肺炎球菌疫苗
RU2701733C1 (ru) * 2018-12-14 2019-10-01 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Живая вакцина на основе штамма пробиотиков ENTEROCOCCUS FAECIUM L3 для профилактики инфекции, вызванной STREPTOCOCCUS PNEUMONIE

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5371197A (en) 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
US5474905A (en) * 1993-11-24 1995-12-12 Research Corporation Technologies Antibodies specific for streptococcus pneumoniae hemin/hemoglobin-binding antigens
US5505947A (en) 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
JP2000511769A (ja) 1996-04-02 2000-09-12 スミスクライン・ビーチャム・コーポレイション 新規化合物
WO1998018930A2 (en) 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae antigens and vaccines
JP2002529046A (ja) 1997-05-06 2002-09-03 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｅｎｔｅｒｏｃｏｃｃｕｓ ｆａｅｃａｌｉｓのポリヌクレオチドおよびポリペプチド
WO1998059071A1 (en) 1997-06-20 1998-12-30 Human Genome Sciences, Inc. Lyme disease vaccines
US7151171B1 (en) 1997-07-02 2006-12-19 sanofi pasteur limited/sanofi pasteur limitée Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US5882885A (en) 1997-07-17 1999-03-16 Smithkline Beecham Corporation Glycogen phosphorylase
US5994101A (en) 1997-07-18 1999-11-30 Smithkline Beecham Corporation DNA encoding gidA1 polypeptides
US6617156B1 (en) 1997-08-15 2003-09-09 Lynn A. Doucette-Stamm Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
US6248558B1 (en) 1998-03-31 2001-06-19 Vanderbilt University Sequence and method for genetic engineering of proteins with cell membrane translocating activity
CN1318103A (zh) 1998-07-27 2001-10-17 微生物技术有限公司 肺炎链球菌的核酸和蛋白质
GB9816337D0 (en) * 1998-07-27 1998-09-23 Cortecs Uk Ltd Proteins
ES2400280T3 (es) * 1998-12-23 2013-04-08 Id Biomedical Corporation Of Quebec Antígenos de estreptococos
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
ES2264419T3 (es) 1999-06-10 2007-01-01 Medimmune, Inc. Vacunas y proteinas de streptococcus pneumoniae.
JP2003520034A (ja) 1999-12-23 2003-07-02 ヴィマックス リミテッド ビルレンス遺伝子、タンパク質、およびそれらの用途
US6783939B2 (en) 2000-07-07 2004-08-31 Alphavax, Inc. Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
NZ583028A (en) 2000-10-27 2011-10-28 Novartis Vaccines & Diagnostic Nucleic acids and proteins from streptococcus groups A & B
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
IL158380A0 (en) 2001-04-16 2004-05-12 Wyeth Corp Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
US20040029129A1 (en) 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US7314974B2 (en) 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
US20090252756A1 (en) 2002-04-02 2009-10-08 Yaffa Mizrachi-Nebenzahl Protein-based streptococcus pneumoniae vaccines
AU2003242955B2 (en) 2002-04-02 2009-04-09 Ben-Gurion University Of The Negev Research And Development Authority Protein-based streptococcus pneumoniae vaccines
US20070053924A1 (en) 2002-08-26 2007-03-08 Herve Tettelin Conserved and specific streptococcal genomes
WO2004020609A2 (en) 2002-08-30 2004-03-11 Tufts University Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
CA2498798A1 (en) 2002-09-20 2004-04-01 Alpharma, Inc. Sustained-release opioid formulations and methods of use
EP2333114A1 (en) * 2003-04-15 2011-06-15 Intercell AG S. pneumoniae antigens
GB0318688D0 (en) 2003-08-08 2003-09-10 Chiron Srl Streptococcus pneumoniae knockout mutants
AU2005319174A1 (en) 2004-12-22 2006-06-29 J. Craig Venter Institute, Inc. Group B Streptococcus
EP1855717A4 (en) 2005-02-11 2009-12-23 Ace Biosciences As ON THE SURFACE STREPTOCOCCUS PNEUMONIAE POLYPEPTIDE
AU2007225238A1 (en) 2006-03-10 2007-09-20 Wyeth Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniae
DK2054431T3 (da) 2006-06-09 2012-01-02 Novartis Ag Konformere af bakterielle adhæsiner
GB0700136D0 (en) 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Process for manufacturing vaccines
WO2008119358A2 (en) 2007-03-30 2008-10-09 Ace Biosciences A/S Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
CN101855362A (zh) 2007-05-18 2010-10-06 美国政府健康及人类服务部，疾病控制和预防中心 用于检测肺炎链球菌的引物和探针
BRPI0811908A2 (pt) 2007-05-25 2014-11-18 Novartis Ag Antígenos de pilus de streptococcus pneumoniae
US20100247547A1 (en) 2007-05-29 2010-09-30 Chen Dong Modulation of the th-17 cell mediated immune responses
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
US20100278819A1 (en) 2007-09-14 2010-11-04 Katholieke Universiteit Leuven Streptococcus pneumoniae vaccines
US7833776B2 (en) 2007-12-12 2010-11-16 National Health Research Institutes Lipidating sequences and use thereof for producing lipidated proteins in E. coli
US8466259B2 (en) 2007-12-07 2013-06-18 National Health Research Institutes Adjuvants
AU2009223727B2 (en) 2008-03-14 2014-09-11 Sanofi Pasteur Biologics, Llc Replication-defective flavivirus vaccines and vaccine vectors
AU2009266924B2 (en) 2008-07-01 2015-12-10 Genocea Biosciences, Inc. Antigen screening system
US20110236470A1 (en) 2008-12-03 2011-09-29 Yaffa Mizrachi Nebenzahl GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
US8287880B2 (en) 2009-06-02 2012-10-16 National Health Research Institutes Lipidated vaccine against dengue virus infection
US8658176B2 (en) 2009-06-22 2014-02-25 National Health Research Institutes Lipidated tumor-associated antigens and immunotherapeutic compositions
WO2010150242A2 (en) 2009-06-25 2010-12-29 Protea Vaccine Technologies Ltd. Immunogenic streptococcus pneumoniae peptides and peptide-multimers
CN107126557A (zh) 2009-06-29 2017-09-05 健诺西生物科学公司 抗肺炎链球菌的疫苗和组合物
WO2011064781A1 (en) 2009-11-30 2011-06-03 Ben-Gurion University Of The Negev Research And Development Authority S. pneumoniae adhesins
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
JP5065434B2 (ja) 2010-04-06 2012-10-31 株式会社日立製作所 管理方法及び管理装置
WO2011128892A2 (en) 2010-04-12 2011-10-20 Protea Vaccine Technologies Ltd. Modified forms of pneumococcal surface immunogenic protein b (psipb)
US20110283062A1 (en) 2010-05-14 2011-11-17 Hitachi, Ltd. Storage apparatus and data retaining method for storage apparatus
WO2012100234A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae

Also Published As

Publication number Publication date
RU2013138563A (ru) 2015-02-27
AU2012207088A1 (en) 2013-05-02
WO2012100233A1 (en) 2012-07-26
RU2623174C2 (ru) 2017-06-22
AU2012207089A1 (en) 2013-05-02
US10188717B2 (en) 2019-01-29
BR112013018642A2 (pt) 2019-04-30
AU2012207089B2 (en) 2016-04-14
KR20140017554A (ko) 2014-02-11
CN103501809B (zh) 2018-08-10
EP2665490A1 (en) 2013-11-27
NZ614460A (en) 2015-08-28
IL227554A0 (en) 2013-09-30
MX2013008358A (es) 2013-09-02
SG192060A1 (en) 2013-08-30
EP2665490B1 (en) 2020-03-04
EP2665490A4 (en) 2015-07-01
CN105833260A (zh) 2016-08-10
US20170157234A1 (en) 2017-06-08
US9393294B2 (en) 2016-07-19
WO2012100234A1 (en) 2012-07-26
CN103501809A (zh) 2014-01-08
JP2014503002A (ja) 2014-02-06
US20120189649A1 (en) 2012-07-26
JP6126993B2 (ja) 2017-05-10
IL227554A (en) 2016-10-31
SG10201600435UA (en) 2016-02-26
MY163871A (en) 2017-10-31
CA2861313A1 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
IN2012DN00791A (es)
MX344120B (es) Vacunas y composiciones contra streptococcus pneumoniae.
MX2017009308A (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
IL235966B (en) Aqueous compositions with a ph level of 6 containing anti-Baffr antibody without fucosylation for use in the treatment of autoimmune diseases
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
MX366368B (es) Metodos para el cuidado oral prebiotico usando un sacarido.
IL227626A0 (en) A compound of 17-il and γ-ifn inhibitors, preparations containing them and their uses
HUE060892T2 (hu) Probiotikus baktériumtörzsek a szájüreg betegségeinek megelõzésére és kezelésére
MX366090B (es) Combinación farmacéutica para usarse en mejorar la tolerancia a la glucosa en pacientes que padecen diabetes de tipo 2.
SI2739615T1 (sl) Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo
TWD166031S (zh) 口含物
EP3069332A4 (en) Reducing health care-associated infections based on hand hygiene
SG11201700089QA (en) Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
MX2016000099A (es) Vacunas sinteticas contra streptococcus pneumoniae tipo 1.
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.
WO2013074048A3 (en) Tablet forms comprising quetiapine fumarate
EP2804627A4 (en) CONDENSED ANTIGEN VACCINES AND COMPOSITIONS AGAINST STREPTOCOCCUS PNEUMONIAE
PH12015501147A1 (en) Synbiotic composition and use thereof
TWD166399S (zh) 飲料分配器之部分
GB201106162D0 (en) Combination vaccine
EP2753932A4 (en) DETERMINATION OF BACTERIAL INFECTIONS OF THE GENUS RICKETTSIA AND, WHERE APPROPRIATE, BORRELIA IN BLOOD-SPENDING PATIENTS WITH DISEASE SYMPTOMS
TWD161574S (zh) 飲料分配器之部分
GB201102090D0 (en) Antigenic polypeptide
MX2013005222A (es) Nuevo adyuvante.
杨盈 On the Application of Iconicity in Poem Translation

Legal Events

Date Code Title Description
FG Grant or registration